Details of the Drug

General Information of Drug (ID: DMRMMAA)

• Drug Name: TARA-002

Indication

Disease Entry	ICD 11	Status	REF
Lymphatic malformation	LA90.1	Phase 2	[1]

• Drug Type: Cell therapy
• Cross-matching ID:
  PubChem CID: 640429
  TTD ID: DNV2Y6
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

References

• [1] ClinicalTrials.gov (NCT05871970) A Phase 2a/b Single Arm Open Label Study to Evaluate the Safety and Efficacy of Intracystic Administration of TARA-002 in Participants Between 6 Months to Less Than 18 Years of Age for the Treatment of Macrocystic and Mixed Cystic Lymphatic Malformations. U.S.National Institutes of Health.